EZH2 and triple-negative breast carcinoma: In line with these findings, a previous paper in triple negative breast cancer, reported that the dual inhibition of AKT and EZH2 induces differentiation from an aggressive basal-like cells to a more differentiated, luminal-like phenotype (68).